{"name":"Shanghai Bovax Biotechnology Co., Ltd.","slug":"shanghai-bovax-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Active Comparator: GARDASIL ®9","genericName":"Active Comparator: GARDASIL ®9","slug":"active-comparator-gardasil-9","indication":"Prevention of cervical cancer caused by HPV types 16, 18, 31, 33, 45, 52, 58","status":"phase_3"}]}],"pipeline":[{"name":"Active Comparator: GARDASIL ®9","genericName":"Active Comparator: GARDASIL ®9","slug":"active-comparator-gardasil-9","phase":"phase_3","mechanism":"GARDASIL 9 is a recombinant human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against nine HPV types to prevent infection and associated cancers.","indications":["Prevention of cervical cancer caused by HPV types 16, 18, 31, 33, 45, 52, 58","Prevention of genital warts caused by HPV types 6, 11","Prevention of anal cancer and other HPV-related cancers"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNQ0Zzd2ZRYW5OYzlhWlFxeGM1MnVMRnVHZmRrZWJsNW1aRlJrSUV6SVF3My1xQmxrcjBvUm40T0pkcFpqeV9senUwU3RLS01QVkdrMkdONG51cDJyUjlHT0w5R1FGblRqYjN2b2dyUWdjbGpTT29wZ2hPQ1VDTmJaXzBKX0pSTlctWVJwM0JWTnppYTlIUWJuVTY4R2lOSlU3MEFQcVdEUFVDSVFMNXZEZWVtLTNVelJyblVENXdZcWxZRWs1U1d0aUtYemtpVXcwdUhsMjZoQk1FXzhabnA0VjdUZWRpYkU?oc=5","date":"2025-11-18","type":"pipeline","source":"GlobeNewswire","summary":"India Human Papillomavirus Vaccine Market Research Report 2025 | Now Available - GlobeNewswire","headline":"India Human Papillomavirus Vaccine Market Research Report 2025 | Now Available","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNLVphSUYyb19XalJIeTdKb3VJRmFCN1F3ZUVtMGhaeFozR3B2THRsblQyYW1zcjFfSVZWMXRmRGtSVmdRSmxzV3FHNXV1amVFWE5VcVhmUlBzMWhPQUhhUVlCbkxkZEk5MTBMUzg4MEFLV1NrTGpqbEtqbHNuRmZGclZDNVgwQS12YlNoNkUwMnJoandxZmFXOGlWcml0dWlSYWsweVVPSnJKaG1kOFU1MnV2NkQwXzM0b3EzQV9uSTliY1ZsZW1OMkRncjJUS21fSmd3?oc=5","date":"2024-06-05","type":"patent","source":"Reuters","summary":"Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic - Reuters","headline":"Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}